comparemela.com

Latest Breaking News On - Pharmaceuticals trading down - Page 6 : comparemela.com

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Recommendation of "Moderate Buy" by Analysts

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages […]

United-states
Bobakr-azamian
Bryan-wahl
Nasdaq
Vanguard-group-inc
Goldman-sachs-group
Tarsus-pharmaceuticals-trading-down
News-ratings-for-tarsus-pharmaceuticals-daily
Healthcare-of-ontario-pension-plan-trust-fund
Institutional-trading-of-tarsus-pharmaceuticals
Tarsus-pharmaceuticals-inc
Tarsus-pharmaceuticals

Verrica Pharmaceuticals (NASDAQ:VRCA) PT Raised to $14.00 at HC Wainwright

Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […]

United-states
Hedge-funds-weigh-in-on-verrica-pharmaceuticals
News-ratings-for-verrica-pharmaceuticals-daily
Avoro-capital-advisors
Nasdaq
Capital-management
Jump-financial
Verrica-pharmaceuticals
Kovitz-investment-group-partners
Verrica-pharmaceuticals-trading-down
Needham-company

PMV Pharmaceuticals (NASDAQ:PMVP) Earns "Buy" Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of PMV Pharmaceuticals (NASDAQ:PMVP – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright also issued estimates for PMV Pharmaceuticals’ Q2 2024 earnings at ($0.31) EPS, Q3 2024 earnings at ($0.33) EPS, Q4 […]

Craig-hallum
Alkeon-capital-management
Capital-management
Pharmaceuticals-inc
Pharmaceuticals-trading-down
Jefferies-financial-group
Vontobel-holding-ltd
Pharmaceuticals-daily
Acadian-asset-management
Jacobs-levy-equity-management-inc
Free-report
Financial-group

First National Advisers LLC Acquires 4,120 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

First National Advisers LLC grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 31.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,032 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,120 shares during the quarter. First National […]

Canada
United-states
Philipl-johnson
Stifel-nicolaus
Neenam-patil
Piper-sandler
Exchange-commission
Nasdaq
Jazz-pharmaceuticals-trading-down
Securities-exchange-commission
First-national-advisers
Royal-bank

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 9.9% in April

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 9.9% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Institutional-trading-of-aurinia-pharmaceuticals
Otsuka-pharmaceutical-co-ltd
Sunbelt-securities-inc
Goldman-sachs-group-inc
Aurinia-pharmaceuticals
Aurinia-pharmaceuticals-inc
Campbell-co-investment-adviser
Armistice-capital
Aurinia-pharmaceuticals-trading-down
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.